Eli Lilly CEO John Lechleiter will retire in December after leading the drugmaker through a challenging period in which it lost U.S. patent protection for several top-selling products.
By The Associated Press, St. Louis Post-Dispatch: Business
Wed, 07/27/2016 - 5:53am
Eli Lilly CEO John Lechleiter will retire in December after leading the drugmaker through a challenging period in which it lost U.S. patent protection for several top-selling products.